Penumbra Inc (PEN)
TCT 2025: STRIKE-PE Analyses Show CAVT Can Improve Functional Outcomes and Quality of Life for Intermediate- and High-Risk PE Patients
TCT 2025: STRIKE-PE Analyses Show CAVT Can Improve Functional Outcomes and Quality of Life for Intermediate- and High-Risk PE Patients
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (91%) **Content type:** Clinical